Study of genetic variants in cancer families
Part of Cancer, Genetic & congenital clinical trials.
This study looks at how a specific DNA genetic change (variant) runs within cancer families. It may help researchers better understand cancer risk and improve genetic testing and interpretation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 18 years old
- You must be part of a family being studied because of a known genetic variant found in a cancer-related diagnostic test
- For the main participant (index case): your variant must be from an approved gene list and classified in a specific way (class 3, 4, or hypomorphic class 5) by the study network
- For relatives: you must be a family member of the index case and included by the study team based on family relationships and cancer history
- All participants must sign written informed consent (selected relatives and the index case)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether DNA (from a tumor or related samples) can help identify inherited cancer risk in people who develop cancer at a young age. It may help families learn more about risk factors and guide future screening or prevention.
This study looks for genetic changes that may explain why some people get cancer earlier or more often than expected. It may help identify cancer risk patterns in you and your family, and guide what doctors watch for next.
This study looks for inherited (family-passed) genetic changes that may raise the risk of lung cancer and related thoracic cancers. It may help people and families understand their genetic risk by collecting health information and sometimes specimens from patients and relatives.
This study helps people who carry a known cancer-related gene variant share information with their close family members. We offer free genetic testing to eligible relatives who have not yet been tested.
This study looks at how parents and children communicate after learning about an inherited (genetic) cancer risk. It may help researchers find better ways to support families in these conversations.
This study tests a tool called GIA (Genetic Information Assistant) that helps people understand genetic testing for cancer risk. You would use the tool on a smartphone or computer during a genetic counseling session.
Hear when a new Genetic Predisposition trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.